Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)

被引：0
|
作者：
Cuppens, K. [1 ]
Lodewyckx, L. [2 ]
Demedts, I. [3 ]
Decoster, L. [4 ]
Colinet, B. [5 ]
Deschepper, K. [6 ]
Janssens, A. [7 ]
Pauwels, P. [8 ]
Galdermans, D. [9 ]
Pieters, T. [10 ]
机构：
[1] Virga Jesse Ziekenhuis, Dept Pulmonol & Thorac Oncol, Hasselt, Belgium
[2] AstraZeneca Nv Sa, Dept Med, Oncol, Groot Bijgaarden, Belgium
[3] AZ Delta, Dept Pulm Dis, Roeselare, Belgium
[4] UZ Brussel, Oncol Ctr, Dept Med Oncol, Jette, Belgium
[5] Grand Hop Charleroi, Dept Pneumol & Thorac Oncol, Charleroi, Belgium
[6] AZ Nikolaas, Pneumol, St Niklaas, Belgium
[7] Univ Hosp Antwerp UZA, Dept Pulmonol & Thorac Oncol, Edegem, Belgium
[8] Univ Hosp Antwerp UZA, Pathol Dept, Edegem, Belgium
[9] ZNA Middelheim, Pneumol, Antwerp, Belgium
[10] Catholic Univ Louvain, Clin Univ St Luc, Dept Pulmonol, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1306
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2000P
引用
收藏
页码：S1117 / S1117
页数：1
相关论文
共 50 条
  • [21] Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients
    Barlesi, F.
    Paz-Ares, L.
    Page, D.
    Shewade, A.
    Lambert, P.
    Mughal, T.
    Gay, L.
    Khorshid, M.
    Arnieri, B.
    Capra, W.
    Foser, S.
    Mascaux, C.
    Bubendorf, L.
    Wang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S459 - S460
  • [22] Afatinib in the treatment of advanced NSCLC with EGFR mutation: An observational real-world study.
    Li, Yun
    Wang, Xiaohua
    Wang, Li
    Kou, Yingying
    Ma, Xianglei
    Feng, Ji Feng
    Xiao, Mingzhe
    Shi, Meiqi
    Tang, Yiqun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] START: Real-world Prospective Study on Sequential Therapy with First-Line Afatinib in Chinese Patients with EGFRm plus Advanced NSCLC
    Zhou, J.
    Xue, Z.
    Li, Q.
    Ling, X.
    Wu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S632 - S633
  • [24] Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm plus NSCLC and Acquired T790M: The Real-World UpSwinG study
    Popat, S.
    Jung, H. A.
    Lee, S. Y.
    Hochmair, M. J.
    Lee, S. H.
    Escriu, C.
    Lee, M. K.
    Migliorino, M. R.
    Lee, Y. C.
    Girard, N.
    Daoud, H.
    Marten, A.
    Miura, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1120 - S1121
  • [25] A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)
    Miura, S.
    Hsia, T.
    Hung, J.
    Jung, H. A.
    Shih, J.
    Park, C.
    Lee, S. H.
    Okamoto, T.
    Ahn, H. K.
    Lee, Y. C.
    Sato, Y.
    Lee, S. S.
    Mascaux, C.
    Daoud, H.
    Maerten, A.
    Popat, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1115 - S1116
  • [26] Real-world long-term outcomes of advanced/metastatic NSCLC patients treated with EGFR TKIs in Nottinghamshire
    Lopez-Escola, C.
    Mengoli, K.
    Sheikh, O.
    Karim, S.
    Sadiq, M.
    [J]. LUNG CANCER, 2020, 139 : S62 - S62
  • [27] Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag)
    Hochmair, M. J.
    Morabito, A.
    Hao, D.
    Yang, C-T.
    Soo, R. A.
    Yang, J. C-H.
    Gucalp, R.
    Halmos, B.
    Wang, L.
    Golembesky, A.
    Maerten, A.
    Cufer, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [28] Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
    Halmos, B.
    Tan, E.
    Soo, R.
    Cadranel, J.
    Lee, M. K.
    Foucher, P.
    Hsia, T.
    Hochmair, M.
    Griesinger, F.
    Hida, T.
    Kim, E.
    Melosky, B.
    Maerten, A.
    Carcereny, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S470 - S471
  • [29] Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
    Hochmair, M. J.
    Morabito, A.
    Hao, D.
    Yang, C.
    Soo, R.
    Yang, J. C.
    Gucalp, R.
    Halmos, B.
    Golembesky, A.
    Maerten, A.
    Cufer, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1045 - S1045
  • [30] Afatinib in EGFR Mutation-Positive (EGFRm plus ) NSCLC Harbouring Uncommon Mutations: Experience in 'Real-World' Clinical Practice
    Brueckl, W.
    Laack, E.
    Hoffmann, C.
    Zhou, C.
    Wu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S670 - S671
12345